The presence of SOX2 and SOX10 cancer stem cell markers in pancreatic tumor derived organoids delineates role of cancer stem cells in therapy resistance in pancreatic cancer (Supplementary Figure S6, S74) (53). The gene discussed is SOX2; the disease is familial pancreatic carcinoma.